Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics

Avenue Therapeutics, Inc. (ATXI): $1.22

0.08 (-6.15%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

ATXI Price/Volume Stats

Current price $1.22 52-week high $15.00
Prev. close $1.30 52-week low $1.22
Day low $1.22 Volume 97,700
Day high $1.33 Avg. volume 903,780
50-day MA $1.77 Dividend yield N/A
200-day MA $2.76 Market Cap 2.51M

ATXI Stock Price Chart Interactive Chart >


Avenue Therapeutics, Inc. (ATXI) Company Bio


Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.


ATXI Latest News Stream


Event/Time News Detail
Loading, please wait...

ATXI Latest Social Stream


Loading social stream, please wait...

View Full ATXI Social Stream

ATXI Price Returns

1-mo -32.65%
3-mo -39.00%
6-mo -51.20%
1-year -88.76%
3-year -99.82%
5-year -99.99%
YTD -39.00%
2024 -83.44%
2023 -86.12%
2022 -91.48%
2021 -84.74%
2020 -38.02%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!